Cellex Inc
Industry
- Medical Devices
See more in Biomedtracker
Latest on Cellex Inc
Scrip
• By Mandy Jackson
The latest third quarter data from the National Venture Capital Association (NVCA) and Pitchbook’s Venture Monitor report confirm recent data compiled by Evaluate Pharma, which showed that VC investme
Scrip
• By Mandy Jackson
Blackstone has raised a new fund called Blackstone Life Sciences Yield (BXLS Yield), providing $1.6bn in additional capital for drug, device and diagnostic developers with late-stage assets. But while
Scrip
• By Joseph Haas
Gene-editing specialist Intellia Therapeutics, Inc. and cell manufacturing firm Cellex Inc said on 22 June that they are teaming up with the private equity group Blackstone Life Sciences to create